#LyX 2.3 created this file. For more info see http://www.lyx.org/
\lyxformat 544
\begin_document
\begin_header
\save_transient_properties true
\origin unavailable
\textclass classicthesis
\use_default_options true
\maintain_unincluded_children false
\language american
\language_package default
\inputencoding utf8
\fontencoding global
\font_roman "default" "default"
\font_sans "default" "default"
\font_typewriter "default" "default"
\font_math "auto" "auto"
\font_default_family default
\use_non_tex_fonts false
\font_sc false
\font_osf false
\font_sf_scale 100 100
\font_tt_scale 100 100
\use_microtype false
\use_dash_ligatures true
\graphics default
\default_output_format default
\output_sync 0
\bibtex_command default
\index_command default
\paperfontsize default
\spacing single
\use_hyperref false
\papersize default
\use_geometry false
\use_package amsmath 1
\use_package amssymb 1
\use_package cancel 1
\use_package esint 0
\use_package mathdots 1
\use_package mathtools 1
\use_package mhchem 1
\use_package stackrel 1
\use_package stmaryrd 1
\use_package undertilde 1
\cite_engine biblatex
\cite_engine_type authoryear
\biblio_style plainnat
\biblatex_bibstyle numeric-comp
\biblatex_citestyle numeric-comp
\use_bibtopic false
\use_indices false
\paperorientation portrait
\suppress_date false
\justification true
\use_refstyle 0
\use_minted 0
\index Index
\shortcut idx
\color #008000
\end_index
\secnumdepth 2
\tocdepth 2
\paragraph_separation indent
\paragraph_indentation default
\is_math_indent 0
\math_numbering_side default
\quotes_style english
\dynamic_quotes 0
\papercolumns 1
\papersides 1
\paperpagestyle default
\tracking_changes false
\output_changes false
\html_math_output 0
\html_css_as_file 0
\html_be_strict false
\end_header

\begin_body

\begin_layout Chapter

\size larger
Introduction
\end_layout

\begin_layout Standard

\size larger
\begin_inset CommandInset label
LatexCommand label
name "ch:Introduction"

\end_inset


\end_layout

\begin_layout Standard

\size larger
An integrated collection of expert systems with the aim of the identification,
 recognition, diagnosis, patient follow-up and help in the treatment journey
 for three main types of cancer: 
\series bold
brain
\series default
,
\series bold
 breast 
\series default
and 
\series bold
gastric (stomach) 
\series default
cancer is proposed to serve both doctors who seek to automate a part of
 the general practicioner's job and use a system that will help along the
 journey of diagnosis, follow-up and treatment, and patients who want their
 questions answered starting from the very first phases before the confirmation
 of the illness to later phases of treatment (e.g: chemotherapy), as well
 as keeping up with how their health is doing so far in an easily accessible
 way.
 The system is planned to be available for both doctors and patients using
 different applications in a way that will make it possible for both parties
 to access crucial data in the right times.
\end_layout

\begin_layout Section
Motivation
\end_layout

\begin_layout Standard

\size larger
By the end of 2018, an estimated 1,735,350 new cases of cancer will be diagnosed
 in the United States alone with an estimated 609,640 people will die as
 a result of the disease.
 By observing different cases from 2011 to 2015, an estimated 0.00439% (around
 439 per 100,000) of men and women are diagnosed with cancer each year,
 while during the same period, the estimated number of deaths resulting
 from cancer was 163 per 100,000.
 Death as a result of cancer is slightly higher in men with an estimated
 197 per 100,000 compared to an estimated 140 per 100,000 for women.
 
\end_layout

\begin_layout Standard

\size larger
According to data collected in the period of 2013-2015, it is estimated
 that 38.4% of both men and women will get diagnosed with cancer at some
 point in their lives.
 
\end_layout

\begin_layout Standard

\size larger
Cancer has impacted societies around the world in different ways, the numbers
 aforementioned show approximately how impactful cancer had been and it
 serves as a wake up call for people who never thought of cancer as a danger
 they might have to anticipate at some point in their lives.
\end_layout

\begin_layout Standard

\size larger
\begin_inset Float figure
placement H
wide false
sideways false
status open

\begin_layout Plain Layout

\size larger
\begin_inset Graphics
	filename /home/ihab/Downloads/lung-cancer-cell-dividing-article.__v80030169.jpg
	scale 50

\end_inset


\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
A dividing lung cancer cell.
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard

\size larger
In the most basic terms, cancer is an umbrella term for a group of related
 diseases that all share a common characteristic: an unstoppable division
 of the body's cells that spread into sorrounding tissues.
 Cancer can basically start in any of the trillions of cells that make up
 the human body; normally, human cells grow and divide to form new cells,
 but the cells grow old or somehow get damaged, they die, and new cells
 take their place.
\end_layout

\begin_layout Standard

\series bold
\size larger
Glycation 
\series default
(or non-enzymatic glycosylation) is the result of a covalent bond formed
 between a sugar molecule (i.e: glucose or fructose) to a protein or lipid
 molecule, without the controlling action of an enzyme.
 Glycation may either occur inside the body (endogenous glycation) or outside
 the body (exogenous glycation).
 
\end_layout

\begin_layout Standard

\series bold
\size larger
Excogenous glycation 
\series default
refers to the formation of 
\series bold
Advanced Glycation Endproducts (AGES)
\series default
 when sugars are cooked with proteins and fats; typically temperatures over
 248 
\begin_inset Formula $\textdegree F$
\end_inset

 (
\begin_inset Formula $\sim120\textdegree C)$
\end_inset

 greatly spur the reactions, that being said, lower temperatures with longer
 (or slow) cooking also promote the formulation.
 Such compounds are absorbed during digestion with about 10% efficiency;
 browning effects are evidence of pre-formed glycations, for example: sugar
 is often an ingredient in many french fries and baked good recipes to promote
 browning.
 Glycation may contribute to the formation of acrylamide a potential carcinogen,
 during cooking.
 
\end_layout

\begin_layout Standard

\size larger
\begin_inset Float figure
placement H
wide false
sideways false
status open

\begin_layout Plain Layout

\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Graphics
	filename /home/ihab/Downloads/Screen-Shot-2016-03-17-at-17.29.09.png
	scale 200

\end_inset


\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
The Glycation Process
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard

\series bold
\size larger
Endogenous glycations 
\series default
describe the type of gylcations occuring mainly in the bloodstream to a
 small percentae of the absorbed simple sugars (e.g: glucose, fructose and
 galactose).
 The effects of fructose were formely drastically underestimated due to
 the use of inaccurate assay techniques, but it turned out to have effects
 that are approximately ten times worse than the effects of glucose which
 is considered the primary body fuel.
 Some AGEs are benign, but some are much more effective than the sugars
 they are derived of.
 AGEs contribute to the development of cancer, along with a massive list
 of other diseases including cardiovascular diseases, usually when covalent
 bonds are formed between the sugars and collagens.
 The list goes on to include Alzheimer's disease as a result of the formation
 of amyloid proteins as a side-product of AGES, deafness due to demyelination.
 Long-lived cells, such as nerves, long-lasting proteins (such as crystallins
 of the lens and cornea), and DNA may accumulate substantial damage over
 time.
 Damage by gylcation results in the stiffness of collagen in the blood vessel
 walls, usually leading to diabetes.
\end_layout

\begin_layout Standard

\size larger
A telomere is a region at the end of a chromosome, often called the tail
 of the chromosome.
 Telomeres usually contain repetitive nucloetide sequences to protect the
 end of the chromosome from deterioration or from fusion with neighbouring
 chromosomes.
 During the process of chromosome replication, the enzymes that duplicate
 DNA can not continue their duplication all the way to the end of the chromose,
 so each time the end of the DNA is shortened, this is mainly contributed
 to the synthesis of Okazaki fragments which require RNA primers attaching
 ahead on the lagging strand.
 Basically, telomeres are truncated during cell divsion; their presence
 protects genes contained in the chromosome from being truncated instead.
 The telomeres themselves are protected by shelterin proteins along with
 the RNA that telomeric DNA encodes (known as TERRA).
 When telomeres get too short, the cell can no longer divide resulting in
 it being inactive or dead; this shortening process is associated aging,
 cancer and death.
\end_layout

\begin_layout Standard

\size larger
When cancer develops, the orderly process of cell division is broken down;
 cells become more and more abnormal, damaged cells survive when they are
 supposed to die, and new cells are formed when they are not needed, these
 new cells divide continuously without stopping and may form tumours.
\end_layout

\begin_layout Standard

\size larger
Cancerous tumours are malignant, meaning they can spread to nearby tissues,
 and as tumours grow, some cancer cells break off and travel to distant
 places in the body through the blood or the lymph system and form new tumours
 in places other than the origin of the tumour.
 In contrast with malignant tumours, benign tumours do not spread to nearby
 areas, and while they can be quite large, once they are removed they usually
 do not grow back; most benign tumours are safe except the ones that grow
 in the brain.
\end_layout

\begin_layout Standard

\size larger
Cancer cells are not as specialized as normal cells, meaning that normal
 cells mature into very distinct cell types while cancerous ones do not,
 that is why cancerous cells keep dividing in an unstoppable fashion.
 That is in the addition to the fact that cancerous cells are programmed
 to ignore signals that tell cells to dividing, a process called programmed
 cell death, or apoptosis, which the body utilizes to get rid of unncessary
 cells.
 
\end_layout

\begin_layout Standard

\size larger
The microenvironment, or the area sorrounding and feeding a tumour could
 be hugely influenced by cancer cells that may be able to affect the normal
 cells, molecules and blood vessels.
 As an example of such an effect, cancer cells could prompt normal cells
 to form blood vessels that supply the tumours with oxygen and nutrients
 which they need to grow.
 Cancer cells can dodge the immune system and specialized cells that protect
 the body from infections and other conditions.
\end_layout

\begin_layout Standard

\size larger
Being a genetic disease, cancer is caused by changes to genes that control
 the way our cells function, especially how they divide and grow.
 Such genetic changes could either be inherited from the patient's parents
 or from errors during the patient's lifetime that occur as cells divide
 or as a result from DNA damage caused by certain environmental exposures,
 e.g: tobacco smoking, consumption of unrefined sugars and grains, radiations
 such as UV rays from the sun.
\end_layout

\begin_layout Section
System Description 
\end_layout

\begin_layout Standard

\size larger
The system is composed of four phases that interact with and complement
 one another to help patients to recognize the symptomps of cancer early
 on, follow their progress and have their questions about chemotherapy answered,
 whie helping doctors to organize and easily access patient's records, support
 in the diagnosis, treatment and postoperative chemotherapy.
 The following is a description of each of the proposed phases.
\end_layout

\begin_layout Subsection

\size larger
Phase 1: Cura General Parctitioner
\end_layout

\begin_layout Standard

\size larger
The first phase in the journey is aimed at the patient before the official
 diagnosis by a doctor.
 Cura General Practicioner is a rule-based system built with the support
 of natural language processing to help to interact with the patients to
 figure out if the symptomps they are experiences can potentially be diagnosed
 as cancer or not.
 If the system suspects the patient is in serious need of help because they
 may have one of the three types of cancer aforementioned they are forwarded
 to the second phase and recommended a suitable doctor who uses the system,
 otherwise they are recommended basic cautionary tips and may be recommended
 with the addresses of nearby doctors specializing in the suspected illnesses
 they may have.
 The result of the session the patient has with the system is a detailed
 report sent to the suggested doctor before progressing to the second phase.
\end_layout

\begin_layout Standard

\size larger
Cura GP is composed of a set of interrelated subsystems, the principal of
 which are:
\end_layout

\begin_layout Enumerate

\size larger
the reasoner: a rule based expert consultant that forms the basis of the
 system and is the main contributor to the medical report sent to the doctor.
\end_layout

\begin_layout Enumerate

\size larger
the natural language processor: a component that helps interpret user messages
 and makes the communication experience a little bit more friendly and easier
 for the patient.
\end_layout

\begin_layout Enumerate

\size larger
the interviewer: the user interface of the system which combines modern
 UI technologies with both the NLP and RBS components to achieve the most
 optimal results
\end_layout

\begin_layout Subsubsection

\size larger
Overview of the Problem Domain
\end_layout

\begin_layout Standard

\size larger
Cura GP is designed to assist patients in the recognition of the symptomps
 they might be experiencing and how they might impact their chance of treatment.
 Cancer is a general term describing a variety of related diseases having
 different prognoses and natural histories.
 
\end_layout

\begin_layout Standard

\size larger
The domain of this particular expert system is not exactly typical; it is
 mainly concerned with the symptomps of the three types of cancer aforementioned
: brain, breast and gaststric cancer, along with all possibly related illnesses;
 for example in the case of gastric cancer the system also deals with the
 symptomps of gastritis, ulcerative colitis and possibly related gastric
 diseases.
 The resources used to help articulate and describe such a domain include
 various researches detailed in the reference section of this book.
\end_layout

\begin_layout Subsubsection

\size larger
Overview of the NLP Brain
\end_layout

\begin_layout Standard

\size larger
The brain of the natural language reasoner is developed through Rivescript,
 an excerpt of the brain is shown as follows:
\begin_inset Newline newline
\end_inset


\begin_inset listings
lstparams "language=Pascal,float=h"
inline false
status open

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
Excerpt of Cura GP Brain
\end_layout

\end_inset

! var name=cura
\end_layout

\begin_layout Plain Layout

\size larger
! array bodypart= breast brain stomach 
\end_layout

\begin_layout Plain Layout

\size larger
! array paintype = burning crampy dull Sharp 
\end_layout

\begin_layout Plain Layout

\size larger
! array painspan= sudden ongoing episodic Steady 
\end_layout

\begin_layout Plain Layout

\size larger
! array painlocation= lower abdomen|upper abdomen|middle abdomen 
\end_layout

\begin_layout Plain Layout

\size larger
! array paintrigger= stress|drinking alcohol|eating certain food|Coughing
 or other jarring movements 
\end_layout

\begin_layout Plain Layout

\size larger
! array painrelief=Antacids|changing position|drinking more water 
\end_layout

\begin_layout Plain Layout

\size larger
< begin
\end_layout

\begin_layout Plain Layout

\size larger
+Describe how you are feeling right now{topic=pain}
\end_layout

\begin_layout Plain Layout

\size larger
>topic pain 
\end_layout

\begin_layout Plain Layout

\size larger
+[*](@bodypart)[*] 
\end_layout

\begin_layout Plain Layout

\size larger
- in which area does it hurt <set pp=<star>> 
\end_layout

\begin_layout Plain Layout

\size larger
+[*](@painlocation)[*] 
\end_layout

\begin_layout Plain Layout

\size larger
-Describe how is the pain like <set pl=<star>> 
\end_layout

\end_inset


\end_layout

\begin_layout Subsection

\size larger
Cura CBR
\end_layout

\begin_layout Standard

\size larger
Cura CBR is designed with the purpose of assisting oncologists in the follow-up
 and analysis of the cases of different patients based on currently used
 therapy protocols.
 Its aim is to extend our knowledge of cancer at the molecular and cellular
 level, both theoretical and experimental, to achieve a system with a proper
 knowledge base that will be as expert as the current technology allows.
\end_layout

\begin_layout Standard

\size larger
Cura CBR system is proposed to be built based on research on hybrid neurosymboli
c models, and motivations for such an approach are:
\end_layout

\begin_layout Enumerate

\size larger
Cognitive processes are heterogenous â€“ a large pool of representations and
 techniques are used.
\end_layout

\begin_layout Enumerate

\size larger
A proper intelligent system can benefit greatly from the use of a combination
 of different techniques, since a single technique can not do everything.
\end_layout

\begin_layout Standard

\size larger
Classical neurosymbolism deals with the integration of neural networks and
 rule based expert systems.
 The approach we are using is different as it utilizes the same techniques
 to combine neural networks with a combination of rule and case based reasoning
 techniques.
\end_layout

\begin_layout Standard

\size larger
Neural networks will form the basis for the entirety of the case-based system
 including the indexing, retrieval, adaptation and learning phases.
\end_layout

\begin_layout Standard

\size larger
\begin_inset Float figure
placement H
wide false
sideways false
status open

\begin_layout Plain Layout

\size larger
\begin_inset Graphics
	filename /home/ihab/Pictures/neuralnet.png
	scale 150

\end_inset


\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
Neural Networks for CBR
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard

\size larger
As shown in figure 1.3, a connectionist implementation of the CBR is proposed,
 three types of neuron are used:
\end_layout

\begin_layout Enumerate

\size larger
\begin_inset Formula $PAV$
\end_inset

 neurons each represent an input attribute.
\end_layout

\begin_layout Enumerate

\size larger
\begin_inset Formula $OC$
\end_inset

 neurons correspond to stored cases as the hidden layer neurons.
\end_layout

\begin_layout Enumerate

\size larger
\begin_inset Formula $DAC$
\end_inset

 each corespond to the neurons describing the decision features.
\end_layout

\begin_layout Standard

\size larger
Weighted connections exist between the input and hidden layers; the weight
 correspond to the importance of the attribute for the determination of
 the input case; when a new case is introduced to the system, the hidden
 layer is activated by the weighted sum of the input signals, if the sum
 is above the threshold then the output layer will be activated.
\end_layout

\begin_layout Itemize

\size larger
The input layer contains a neuron for each attribute value.
\end_layout

\begin_layout Itemize

\size larger
the hidden layer contains m groups of neurons.
 Each group has 
\begin_inset Formula $l$
\end_inset

 neurons and neuron 
\begin_inset Formula $A_{ik}$
\end_inset

 has 
\begin_inset Formula $n_{i}$
\end_inset

 connections from the neurons 
\begin_inset Formula $a_{i1},\cdots,a_{in_{i}}$
\end_inset

in the input layer.
 Weights connecting 
\begin_inset Formula $A_{ik}$
\end_inset

to neuron 
\begin_inset Formula $a_{ik}$
\end_inset

 to neuron 
\begin_inset Formula $a_{ij}$
\end_inset

 are given by:
\begin_inset Newline newline
\end_inset


\begin_inset Formula 
\begin{equation}
W(A_{ik})_{j}=P(A_{i}=a_{ij}|C=c_{k})
\end{equation}

\end_inset


\begin_inset Newline newline
\end_inset


\begin_inset Formula $W(A_{ik})_{j}$
\end_inset

 is the probability that the attribute 
\begin_inset Formula $A_{ik}$
\end_inset

 takes the value 
\begin_inset Formula $a_{ij}$
\end_inset

 given that the observed patient belongs matches a previous patient (or
 case) 
\begin_inset Formula $c_{k}$
\end_inset

.
 The activation of 
\begin_inset Formula $A_{ik}$
\end_inset

 is achieved by:
\begin_inset Formula 
\begin{equation}
S(A_{ik})=\sum_{j=1}^{n}W(A_{ik})_{j}\times S(a_{ij})
\end{equation}

\end_inset


\end_layout

\begin_layout Itemize

\size larger
The output layer contains 
\begin_inset Formula $l$
\end_inset

 neurons and each corresponds to a previous case 
\begin_inset Formula $c_{k}$
\end_inset

.
 The activation is computed by:
\begin_inset Newline newline
\end_inset


\begin_inset Formula 
\begin{equation}
S(c_{k})=\theta_{k}\times\prod_{i=1}^{m}S(A_{ik})
\end{equation}

\end_inset


\begin_inset Newline newline
\end_inset

where 
\begin_inset Formula $\theta_{k}=P(C=c_{k})$
\end_inset

 is a constant stocked in the neuron 
\begin_inset Formula $c_{k}$
\end_inset

.
\end_layout

\begin_layout Standard

\size larger
This approach of forward propagation allows to perform retrieval of similar
 cases; the hidden layer corresponds to similariy measures.
 As for adaptation, the probabilities can be retro-propagated which allows
 memorized cases to contribute to the adaptation process.
 The retro-propagation implies updating activations in the hidden layer
 as follows:
\end_layout

\begin_layout Standard

\size larger
\begin_inset Formula 
\[
S(A_{ik})=\frac{S(c_{k})}{S(A_{ik})}
\]

\end_inset


\end_layout

\begin_layout Standard

\size larger
Activations of input layer neurons are updated using the following formula:
 
\end_layout

\begin_layout Standard

\size larger
\begin_inset Formula 
\[
S(a_{ij})=S(a_{ij})\times\sum_{k=1}^{l}W(a_{ij})_{k}\times S(A_{ik})
\]

\end_inset


\end_layout

\begin_layout Standard

\size larger
where 
\begin_inset Formula $W(a_{ij})_{k}$
\end_inset

 is the weight from 
\begin_inset Formula $A_{ik}$
\end_inset

 to 
\begin_inset Formula $a_{ij},$
\end_inset

with a value of 
\begin_inset Formula $P(a_{ij}|c_{k})$
\end_inset

.
\end_layout

\begin_layout Section
System Requirements 
\end_layout

\begin_layout Subsection

\size larger
Functional Requirements
\end_layout

\begin_layout Standard

\size larger
\begin_inset Float figure
placement H
wide false
sideways false
status open

\begin_layout Plain Layout

\size larger
\begin_inset Graphics
	filename /home/ihab/Downloads/Untitled Diagram (1).png
	scale 60

\end_inset


\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
Context Diagram
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Enumerate

\series bold
\size larger
Interface Requirements:
\end_layout

\begin_deeper
\begin_layout Enumerate

\size larger
All interfaces shall be easy to use.
\end_layout

\begin_layout Enumerate

\size larger
NLP shall be implemented in the first phase to aid users in their description
 of their symptomps.
\end_layout

\end_deeper
\begin_layout Enumerate

\size larger
Cases shall be implemented in such a way as appropriate cases can be easily
 and correctly retrieved by oncologists.
\end_layout

\begin_layout Enumerate

\size larger
Patient reports resulting from the general practitioner shall be sent in
 a proper form to the oncologist prior to the CBR phase.
\end_layout

\begin_layout Enumerate

\size larger
The system shall be flexible as to accomodate patient follow-ups and visits.
 
\end_layout

\begin_layout Subsection

\size larger
Non-Functional Requirements
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Usability Requirements:
\end_layout

\begin_deeper
\begin_layout Enumerate

\size larger
Minimizing impact of errors 
\end_layout

\begin_layout Enumerate

\size larger
Adapting to user needs
\end_layout

\begin_layout Enumerate

\size larger
Improved human-computer interaction through better UX.
\end_layout

\begin_layout Enumerate

\size larger
Speed
\end_layout

\end_deeper
\begin_layout Enumerate

\series bold
\size larger
Efficiency Requirements:
\end_layout

\begin_deeper
\begin_layout Enumerate

\size larger
performance 
\end_layout

\begin_deeper
\begin_layout Enumerate

\size larger
Transaction processing
\end_layout

\begin_layout Enumerate

\size larger
User / Event Response Time 
\end_layout

\begin_layout Enumerate

\size larger
Screen Refresh Time 
\end_layout

\end_deeper
\begin_layout Enumerate

\size larger
Space: the site requirement spaces is good enough to handle website
\end_layout

\end_deeper
\begin_layout Enumerate

\series bold
\size larger
Dependability Requirement
\series default
s: users shall enjoy all their privacy rights restricting unauthorized access
 to their records and data.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Security Requirements: 
\begin_inset Newline newline
\end_inset


\series default
The implementation and use of top-notch security algorithms to protect users
 sensitive and personal data.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Scalability Requirement
\series default
:
\begin_inset Newline newline
\end_inset

The system shall be scalable to a very flexible degree in its various phases,
 especially in the second and fourth phases, or the CBR system and the marketpla
ce where doctors are encouraged by means of an economic game to add their
 data sets, and by the natural way the CBR system learns over time from
 follow-ups with patients along their treatment journey.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Operational Requirements:
\series default

\begin_inset Newline newline
\end_inset

System servers shall be up and running around the clock to help both doctors
 and patients access crucial data at all times.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Development Requirements:
\begin_inset Newline newline
\end_inset


\series default
The system shall be flexible and extremely dynamic.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Implementation requirements:
\end_layout

\begin_deeper
\begin_layout Enumerate

\size larger
Parallel processing accross server and client.
\end_layout

\begin_layout Enumerate

\size larger
Support for different languages.
\end_layout

\begin_layout Enumerate

\size larger
Cross-platform support.
\end_layout

\begin_layout Enumerate

\size larger
Database integrity.
 
\end_layout

\end_deeper
\begin_layout Enumerate

\series bold
\size larger
Fault tolerance: 
\series default
the system shall be able to continue operating properly in the event of
 the failure of one or more of its main components.
 A high-availability approach shall be used.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Backup
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Interoperability: 
\series default
the different phase of the system shall be interoperable with one another
 and with other systems as well through a properly developed API.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Testability: 
\series default
different phases of the system shall be subjected to different kinds of
 tests from unit tests to integration tests.
\end_layout

\begin_layout Enumerate

\series bold
\size larger
Integrability: 
\series default
the different phases of the system shall be integrated easily.
\end_layout

\begin_layout Section
Advantages and Drawbacks
\end_layout

\begin_layout Subsection

\size larger
Advantages:
\end_layout

\begin_layout Enumerate

\size larger
Easily accessible for patients and doctors.
\end_layout

\begin_layout Enumerate

\size larger
CBR learns more about different patients and cases over time.
\end_layout

\begin_layout Enumerate

\size larger
The system is fed with more information over time, hence the system will
 develop further as the knowledge about cancer accumulates and develops
 over time.
\end_layout

\begin_layout Enumerate

\size larger
The system can still reason with missing information about the patient by
 piecing together data about similar patients.
\end_layout

\begin_layout Enumerate

\size larger
Oncologists can record measures of success or failure of previously suggested
 solutions which the system uses to know what caused those failures and
 predict future failures.
\end_layout

\begin_layout Enumerate

\size larger
Economic games are employed to incentivize oncologists to share data sets
 that are relevant to cancer research.
\end_layout

\begin_layout Subsection

\size larger
Drawbacks:
\end_layout

\begin_layout Enumerate

\size larger
The system does not cover all known types of cancer.
\end_layout

\begin_layout Enumerate

\size larger
The system might not be convenient for patients throughout the entire recognitio
n and treatment process.
\end_layout

\begin_layout Enumerate

\size larger
The system might not be as efficient right from the beginning, but this
 is solvable with the progression of time.
\end_layout

\begin_layout Section
Research Methodology
\end_layout

\begin_layout Standard

\size larger
\begin_inset Graphics
	filename /home/ihab/Downloads/collect.jpg
	scale 150

\end_inset


\end_layout

\begin_layout Subsection

\size larger
Research Strategy
\end_layout

\begin_layout Standard

\size larger
The research done in this project is rather an applied one, based on numerous
 previous academic and industrial research spanning across numerous fields
 including bioinformatics, mathematical biology, blockchain among others.
 As such, our research took the form of a new improvised and revised version
 of a collection of previous researches in the aforementioned fields.
\end_layout

\begin_layout Subsection

\size larger
Goal
\end_layout

\begin_layout Standard

\size larger
\lang english
In an endeavour to help oncologists do a better job managing, analyzing,
 treating and following up with their patient's health, we set out to develop
 and implement a proper set of tools built based on years of research in
 fields like mathematical biology, bioinfomatics, computer science, artificial
 intelligence and medical research by dozens of passionate scientists in
 all of the aforementioned fields.
 And thus to realize this mission we set out a goal for CuraCG is to extend
 our knowledge of cancer at the molecular and cellular level, both theoretical
 and experimental, to achieve a system with a proper knowledge base that
 will be as knowledgeable as the current technology allows.
\end_layout

\begin_layout Subsection

\size larger
Objectives
\end_layout

\begin_layout Enumerate

\size larger
Implement a general practitioner that helps diagnose the user by means of
 an interactive NLP-powered chatbot.
\end_layout

\begin_layout Enumerate

\size larger
Implement an expert system that concludes the major communication link between
 the oncologist, the patient and his visits, along with a case-based reasoning
 component that creates knowledge based on cases from its casebase.
\end_layout

\begin_layout Enumerate

\size larger
Allow ongologists to monitor, moderate and follow-up patient treatment and
 gain insights on its effectiveness.
\end_layout

\begin_layout Enumerate

\size larger
Provide a collaborative platform for oncologists and scientists using Blockchain
 technology, incentivizing them to share their datasets and vote on current
 ones.
\end_layout

\begin_layout Subsection

\size larger
Research Method - Qualitative versus Quantitative Techniques
\end_layout

\begin_layout Standard

\size larger
In order to carry out research that would be beneficial to the point where
 it would help to achieve the objectives listed in 1.5.3, a mixed approach
 of both qualitative and quantitative research was applied.
 Briefly, qualitative research could be the approach to use if the sample
 size is appropriately small, butu its outcomes are not measurable nor quantifia
ble.
 Yet, it offers a complete description and analysis of the topics being
 examined.
 Quantitative research focuses on classifying features, counting them and
 constructing statistical models to explain the observations.
\end_layout

\begin_layout Standard

\size larger
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout

\size larger
\begin_inset Tabular
<lyxtabular version="3" rows="7" columns="2">
<features islongtable="true" longtabularalignment="center">
<column alignment="center" valignment="top" width="30page%">
<column alignment="center" valignment="top" width="30page%">
<row>
<cell alignment="center" valignment="top" topline="true" bottomline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
\size larger
Qualitative
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
\size larger
Quantitative
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
The aim is providing detailed, complete descriptions.
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
The aim is classifying features, counting them and constructing statistical
 models to explain the observations.
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Recommended during the early phases of research.
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Recommended in later phases in the research.
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
The design emerges as the study unfolds.
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
The study is designed carefully before data is collected.
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Data is in the form of words, pictures or objects.
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Data is in the form of numbers and statistics.
 
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Subjective
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Objective
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" topline="true" bottomline="true" leftline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
Time consuming, and less able to generalize to independent data
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" leftline="true" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\size larger
More efficient, and could be cross-validated
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\end_layout

\begin_layout Plain Layout

\size larger
\begin_inset Caption Standard

\begin_layout Plain Layout
Qualitative versus Quantitative Research
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsection

\size larger
Research Questions
\end_layout

\begin_layout Enumerate

\size larger
How widespread are the cancers being considered (brain, breast and stomach)?
\end_layout

\begin_layout Enumerate

\size larger
How significant are the symptoms in recognizing the cancers in early stages?
\end_layout

\begin_layout Enumerate

\size larger
How important is it to discover the cancer in an early stage?
\end_layout

\begin_layout Enumerate

\size larger
What are the environmental factors affecting the considered cancers?
\end_layout

\begin_layout Enumerate

\size larger
What are the words most associated to each of the considered cancers?
\end_layout

\begin_layout Enumerate

\size larger
What are the features of each cancer most useful for indexing in a case-based
 system?
\end_layout

\begin_layout Enumerate

\size larger
What are the features most interesting in an MRI/endoscopy?
\end_layout

\end_body
\end_document
